IMMUNOCHARGING Trademark

Trademark Overview


On Wednesday, November 18, 2020, a trademark application was filed for IMMUNOCHARGING with the United States Patent and Trademark Office. The USPTO has given the IMMUNOCHARGING trademark a serial number of 90326590. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 4, 2023. This trademark is owned by Celularity Inc.. The IMMUNOCHARGING trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; surgical implants comprised of living tissue, namely, human amniotic membrane and human chorionic membrane intended for subsequent implantation; surgical implants comprised of living tissue, namely, human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use in the nature of biological preparations, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treating cancer or other disease-associated antigen; pharmaceutical preparations for wounds, namely, biological ...

Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research

Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, ...
immunocharging

General Information


Serial Number90326590
Word MarkIMMUNOCHARGING
Filing DateWednesday, November 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesCells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; surgical implants comprised of living tissue, namely, human amniotic membrane and human chorionic membrane intended for subsequent implantation; surgical implants comprised of living tissue, namely, human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use in the nature of biological preparations, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treating cancer or other disease-associated antigen; pharmaceutical preparations for wounds, namely, biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; written instructional materials distributed in connection with the aforesaid goods packaged with the goods; biological products for medical use, namely, biological preparations in the nature of placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treatment of cancer or other disease-associated antigen
Pseudo MarkIMMUNO CHARGING
Goods and ServicesBioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
Goods and ServicesResearch, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelularity Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Party NameCelularity Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 27, 2022SOU EXTENSION 3 GRANTED
Tuesday, December 27, 2022SOU EXTENSION 3 FILED
Tuesday, December 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 5, 2022SOU EXTENSION 2 GRANTED
Tuesday, July 5, 2022SOU EXTENSION 2 FILED
Tuesday, July 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 1 GRANTED
Monday, January 3, 2022SOU EXTENSION 1 FILED
Monday, January 3, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2021EXAMINER'S AMENDMENT ENTERED
Monday, May 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 3, 2021EXAMINERS AMENDMENT E-MAILED
Monday, May 3, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, April 30, 2021ASSIGNED TO EXAMINER
Thursday, January 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 21, 2020NEW APPLICATION ENTERED